Epidemiology of rubella infections in Austria: Important lessons to be learned

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 6, 2004, Pages 502-505

  Falkensammer, B ^a   Walder, G ^a   Busch, D ^a   Giessauf A ^a   Dierich, M ^a   Wurzner R ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISTREPTOLYSIN; C REACTIVE PROTEIN; VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRIA; CHILD; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; HYGIENE; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RUBELLA; RUBELLA VIRUS; SOCIAL MEDICINE; TECHNIQUE; TITRIMETRY; TREATMENT PLANNING; UNIVERSITY; VIRUS DETECTION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AUSTRIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RUBELLA; RUBELLA VACCINE; RUBELLA VIRUS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; VACCINATION;

EID: 3142554355     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1138-0     Document Type: Article

References (15)

1. Reef SE, Frey TK, Theall K, Abernathy E, Burnett CL, Icenogle J, McCauley MM, Wharton M (2002) The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA 287:464-472
2. WHO position paper (2000) Rubella vaccines. Wkly Epidemiol Rec 75:161-169
3. Hermann KL (1985) Available rubella serological tests. Rev Infect Dis 7:108-112
4. Pedneault L, Zrein M, Robillard L, Landry F, Lacroix M, Joncas J (1994) Comparison of novel synthetic peptide-based DETECT-RUBELLA enzyme immunoassays with Enzygnost and IMx for detection of rubella-specific immunoglobulin G. J Clin Microbiol 32:1085-1087
5. Gießauf A, Letschka T, Walder G, Dierich MP, Wuerzner R (2004) A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity. J Immunol Methods 287:1-11
6. Zrein M, Joncas JH, Pedneault L, Robillard L, Dwyer RJ, Lacroix M (1993) Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination. J Clin Microbiol 31:1521-1524
7. Mitchell LA, Zhang T, Ho M, Decarie D, Tingle AJ, Zrein M, Lacroix M (1992) Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay. J Clin Microbiol 30:1841-1847
8. Smith CA, Petty RE, Tingle AJ (1987) Rubella virus and arthritis. Rheum Dis Clin North Am 13:265-274
9. Ozsoylu S, Kanra G, Savas G (1797) Thrombocytopenic purpura related to rubella infection. Pediatrics 62:567-569
10. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO (2002) Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 16:1119-1129
11. Kahn JO, Walker BD (1998) Acute human immunodeficiency virus type 1 infection. N Engl J Med 339:33-39
12. Enders G (1991) Infektionen und Impfungen in der Schwangerschaft. Urban & Schwarzenberg, Munich, pp 9-36
13. Health Advisory Board to the Austrian Government (Oberster Sanitätsrat) (2003) Impfplan für 2004 für Österreich http:// www.bmgf.gv.at/cms/site/attachments/1/4/0/CH0016/CMS1038913010412/ impfplan_2004.pdf
14. Ringler M, Gobel G, Most J, Weithaler K (2003) Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children. Eur J Epidemiol 18:161-170
15. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J (2002) Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 324:393-396